Product image of Magnesiocard (Magnesium Aspartate Hydrochloride) supplied by GNH India

Magnesiocard

Active Ingredient:
Magnesium Aspartate Hydrochloride
Origin:
EU

Magnesiocard (Magnesium Aspartate Hydrochloride)

Magnesium Aspartate Hydrochloride, the active ingredient in Magnesiocard, is a magnesium supplement presented as an intravenous solution for intravenous use. It is employed to treat magnesium deficiency and hypomagnesemia in patients requiring rapid correction of low serum magnesium levels.

GNH India supplies Magnesiocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Verla-Pharm Arzneimittel Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Magnesiocard is used to address conditions related to low magnesium levels and associated electrolyte disturbances.

  • Magnesium deficiency: restores normal magnesium concentrations in patients with inadequate dietary intake or losses.
  • Hypomagnesemia: rapidly corrects low serum magnesium in acute care settings.
  • Electrolyte imbalance: supports overall electrolyte homeostasis during critical illness or postoperative recovery.

How It Works

  • Magnesium Aspartate Hydrochloride dissociates to release magnesium ions, which serve as essential cofactors for numerous enzymatic reactions, including ATP synthesis, protein synthesis, and nucleic acid metabolism. The ions help maintain normal electrolyte balance, stabilize cell membranes, and modulate neuromuscular and cardiac excitability, thereby correcting deficiencies and supporting physiological functions.

Side Effects

Magnesiocard may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects

  • Flushing or warmth at the infusion site.
  • Nausea or mild gastrointestinal discomfort.
  • Headache or dizziness.
  • Transient hypotension during rapid infusion.
  • Mild muscle weakness.

Serious or Rare Side Effects

  • Severe hypotension or cardiovascular collapse.
  • Cardiac arrhythmias, including bradycardia.
  • Respiratory depression or apnea.
  • Hypermagnesemia leading to neuromuscular blockade.
  • Anaphylactic or severe allergic reactions.

Precautions & Warnings

When using Magnesiocard, clinicians should observe several safety measures.

  • Assess baseline serum magnesium: confirm deficiency before infusion.
  • Monitor cardiac rhythm: watch for arrhythmias during and after administration.
  • Adjust dose in renal impairment: reduced clearance may increase risk of hypermagnesemia.
  • Avoid rapid infusion: administer over the recommended time to prevent hypotension.
  • Use aseptic technique: maintain sterility of the IV solution.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Magnesiocard can interact with other medications, requiring careful management.

Major Interactions (Avoid)

  • Neuromuscular blocking agents: may potentiate muscle relaxation and respiratory depression.
  • Calcium channel blockers: additive effects on cardiac conduction and blood pressure.
  • Digoxin: increased risk of toxicity due to altered electrolyte balance.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may enhance magnesium loss, requiring dose adjustments.
  • ACE inhibitors: potential for additive hypotensive effects.
  • Aminoglycoside antibiotics: increased risk of nephrotoxicity and altered magnesium handling.

Frequently Asked Questions

Magnesiocard is an intravenous magnesium supplement used to treat magnesium deficiency and hypomagnesemia, helping to restore normal serum magnesium levels and support electrolyte balance in acute medical settings.

The compound releases magnesium ions that act as essential cofactors in many enzymatic processes, stabilize cell membranes, and regulate neuromuscular and cardiac activity, thereby correcting low magnesium concentrations and maintaining electrolyte homeostasis.

The dosage of Magnesiocard is determined by the prescribing clinician based on the patient’s serum magnesium level, clinical condition, renal function, and therapeutic goals. Specific dosing regimens are not provided here.

Safety data for Magnesium Aspartate Hydrochloride in pregnancy and lactation are limited. Clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Magnesiocard delivers magnesium as Magnesium Aspartate Hydrochloride in an injectable form, allowing rapid correction of low magnesium levels. Oral magnesium salts such as magnesium oxide act more slowly and may have lower bioavailability, making Magnesiocard preferable in acute or critical care situations.

Magnesiocard should be stored at 2‑8 °C, kept refrigerated, protected from light, and not frozen or shaken. Maintaining the cold chain preserves the solution’s stability and sterility.

Magnesiocard is administered intravenously by a healthcare professional. The solution is infused over a controlled period, typically using an infusion pump, to avoid rapid changes in serum magnesium and minimize cardiovascular effects.

Serious risks include severe hypotension, cardiac arrhythmias, respiratory depression, hypermagnesemia leading to neuromuscular blockade, and rare anaphylactic reactions. Continuous monitoring of vital signs and serum magnesium is essential during therapy.

Magnesiocard is contraindicated in patients with known hypersensitivity to magnesium salts, severe renal impairment where clearance is compromised, and in those with existing hypermagnesemia. Caution is also advised for individuals on interacting medications such as neuromuscular blockers or calcium channel blockers.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Magnesium Aspartate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT